FTC Takes Action Against Pharmacy Benefit Managers for Inflated Drug Costs

Thursday, 11 July 2024, 12:30

The Federal Trade Commission (FTC) is set to sue major pharmacy benefit managers, including Express Scripts, Caremark, and OptumRx, for their role in driving up prescription drug prices. These three companies dominate 80% of the U.S. market, sparking concerns over anti-competitive behavior and price manipulation. The lawsuit aims to address the high costs of prescription medications and hold these middlemen accountable, potentially leading to a reshaping of the pharmaceutical supply chain.

Gizmodo — FTC Takes Action Against Pharmacy Benefit Managers for Inflated Drug Costs

FTC Lawsuit Against Prescription Drug Middlemen

The Federal Trade Commission is taking legal action against major pharmacy benefit managers in the U.S.

Key Points:

Market Dominance: Express Scripts, Caremark, and OptumRx control 80% of the prescriptions in the country.
Price Manipulation: Concerns over inflated drug costs and anti-competitive practices.
Lawsuit Impact: FTC lawsuit aims to address high drug prices and hold middlemen accountable.

The lawsuit could reshape the pharmaceutical supply chain and potentially lower prescription drug costs.

This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.

FTC Lawsuit Against Prescription Drug Middlemen

Key Points:

Related posts